NEW YORK (GenomeWeb News) – CombiMatrix today said that Pathology, Inc. will market and distribute its chromosomal microarray tests for "products of conception" testing in designated areas in the US.

Products of conception testing enables physicians to better determine if there is a genetic cause behind a miscarriage or multiple events, said Irvine, Calif.-based CombiMatrix.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.